Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health services tags : Biomidwest save search
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
Published: 2024-03-01 (Crawled : 12:00) - biospace.com/
BDSX | $1.26 -1.56% -1.59% 7.1K
|
Health Services
|
| O: 23.38%
H: 1.58%
C: -16.84%
business year results
CENTENE TO PRESENT AT BARCLAYS 26TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Published: 2024-02-29 (Crawled : 00:00) - biospace.com/
CNC | $76.19 0.46% -0.12% 26
|
Health Services
|
| O: -0.06%
H: 0.34%
C: 0.11%
conference global
Premier, Inc.’s PINC AI™ InflowHealth Solution Receives HFMA Peer Review Designation
Published: 2023-06-07 (Crawled : 18:00) - biospace.com/
PINC | $21.12 0.43% 0.45% 1.2M
|
Health Services
|
| O: 0.08%
H: 0.81%
C: 0.15%
solution review designation
Forge Biologics and Labcorp Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration
Published: 2023-05-03 (Crawled : 13:20) - biospace.com/
LH 4 | $207.94 -0.01% -3.33% 790K
|
Health Services
|
| O: 0.89%
H: 0.66%
C: -0.87%
collaboration therapy
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
Published: 2023-04-27 (Crawled : 11:00) - biospace.com/
BDSX | $1.26 -1.56% -1.59% 7.1K
|
Health Services
|
| O: 0.0%
H: 0.31%
C: -3.33%
report financial results
Centene Corporation Reports First Quarter 2023 Results
Published: 2023-04-25 (Crawled : 11:00) - biospace.com/
CNC | $76.19 0.46% -0.12% 26
|
Health Services
|
| O: 2.31%
H: 2.09%
C: 0.1%
corporation results
CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE
Published: 2022-12-16 (Crawled : 13:00) - biospace.com/
CNC | $76.19 0.46% -0.12% 26
|
Health Services
|
| O: 0.17%
H: 2.55%
C: 1.18%
corporation
DaVita Clinical Research Showcases Chronic Kidney Disease and Rare Disease Network, Presents New Research Findings at Kidney Week 2022
Published: 2022-11-03 (Crawled : 11:00) - biospace.com/
DVA | News | $132.74 -0.87% -3.43% 2
|
Health Services
|
| O: 0.0%
H: 0.0%
C: -1.75%
rare research disease kidney week
Open System Imaging Deploys eRAD RIS
Published: 2022-08-09 (Crawled : 11:00) - biospace.com/
RDNT | News | $48.67 -0.33% -0.23% 500K
|
Health Services
|
| O: 0.19%
H: 1.66%
C: -5.87%
system imaging
Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights
Published: 2022-08-04 (Crawled : 22:00) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: 7.14%
H: 2.57%
C: -3.75%
results
Biodesix Announces Second Quarter 2022 Results and Highlights
Published: 2022-08-04 (Crawled : 11:00) - biospace.com/
BDSX | $1.26 -1.56% -1.59% 7.1K
|
Health Services
|
| O: 5.07%
H: 1.38%
C: -0.34%
results
NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
Published: 2022-06-21 (Crawled : 08:00) - biospace.com/
NEO | $14.03 -0.92% -0.93% 540K
|
Health Services
|
| O: 6.81%
H: 0.0%
C: 0.0%
test potential cancer diagnostic breast cancer mrd detection chirp study ctdna analysis her2- her2
Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer
Published: 2022-03-29 (Crawled : 11:00) - biospace.com/
BDSX | $1.26 -1.56% -1.59% 7.1K
|
Health Services
|
| O: 9.77%
H: 0.0%
C: -5.24%
cancer
Aptinyx Reports Fourth Quarter and Full Year 2021 Results and Highlights
Published: 2022-03-23 (Crawled : 21:00) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: -0.32%
H: 1.95%
C: -4.22%
results
Aptinyx to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 23, 2022
Published: 2022-03-09 (Crawled : 13:30) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: 5.56%
H: 3.62%
C: 1.97%
day financial results report results
Aptinyx to Participate in the 42nd Annual Cowen Health Care Conference
Published: 2022-03-01 (Crawled : 15:30) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: -1.64%
H: 9.97%
C: 7.02%
health conference
CENTENE OREGON HEALTH PLAN ACHIEVES NCQA ACCREDITATION
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
CNC | $76.19 0.46% -0.12% 26
|
Health Services
|
| O: 1.34%
H: 1.37%
C: 1.17%
health
Aptinyx Hosts Virtual Portfolio Review Event to Showcase NYX-2925 in Chronic Pain and Provide Update on Clinical Development Programs
Published: 2022-02-09 (Crawled : 13:00) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: 1.64%
H: 9.35%
C: 8.06%
nyx-2925 chronic pain program
Aptinyx Announces Formation of Scientific Advisory Board
Published: 2022-02-03 (Crawled : 13:30) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: -3.58%
H: 0.0%
C: 0.0%
ces
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors
Published: 2022-01-12 (Crawled : 20:00) - biospace.com/
LH 4 | $207.94 -0.01% -3.33% 790K
|
Health Services
|
| O: -1.49%
H: 0.0%
C: -1.67%
treatment solid tumors genomic trial potential work test
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.